Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fort Myers, FL
NPI
1750678520
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8380 Riverwalk Park Blvd Ste 200
Fort Myers, FL, 33919
Phone (239) 938-1750
Groups this clinician bills Medicare through
Medicare paid, 2024
$171K
4,539 services
Medicare patients, 2024
641
Average age 74
Drug cost, 2024
$5.7M
6,928 prescriptions
Company payments, 2025
$2,525
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shayhira Suazo Herrera was code 99214 (office e&m - established), 1,102 times for 580 patients. In total Shayhira Suazo Herrera billed 4,539 services in 49 codes, and Medicare paid $171K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,102 | 580 | $91.99 | $101K |
| 36415 Venipuncture Blood Collection | Office | 516 | 307 | $8.63 | $4,455 |
| 80053 Clinical Chemistry | Office | 370 | 227 | $10.27 | $3,798 |
| 95251 Test - Miscellaneous | Office | 338 | 156 | $25.61 | $8,655 |
| 84439 Clinical Chemistry | Office | 305 | 187 | $8.81 | $2,687 |
| 84443 Clinical Chemistry | Office | 292 | 180 | $16.40 | $4,790 |
| 83036 Blood Count | Office | 218 | 134 | $9.39 | $2,047 |
| 80061 Clinical Chemistry | Office | 213 | 129 | $13.00 | $2,768 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 179 | 163 | $12.49 | $2,235 |
| 82043 Clinical Chemistry | Office | 152 | 104 | $5.55 | $843 |
| 82570 Clinical Chemistry | Office | 152 | 104 | $4.98 | $757 |
| 99204 Office E&M - New | Office | 120 | 120 | $114.16 | $14K |
| 84480 Clinical Chemistry | Office | 113 | 74 | $13.90 | $1,571 |
| 82306 Clinical Chemistry | Office | 112 | 87 | $29.01 | $3,249 |
| 83970 Clinical Chemistry | Office | 55 | 39 | $40.45 | $2,225 |
By year: 2022 $139K for 5,744 services; 2023 $182K for 6,406 services; 2024 $171K for 4,539 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 516 | 307 | $8.63 | $4,455 |
| 80053 Clinical Chemistry | 370 | 227 | $10.27 | $3,798 |
| 84439 Clinical Chemistry | 305 | 187 | $8.81 | $2,687 |
| 84443 Clinical Chemistry | 292 | 180 | $16.40 | $4,790 |
| 83036 Blood Count | 218 | 134 | $9.39 | $2,047 |
| 80061 Clinical Chemistry | 213 | 129 | $13.00 | $2,768 |
| 82570 Clinical Chemistry | 152 | 104 | $4.98 | $757 |
| 82043 Clinical Chemistry | 152 | 104 | $5.55 | $843 |
| 84480 Clinical Chemistry | 113 | 74 | $13.90 | $1,571 |
| 82306 Clinical Chemistry | 112 | 87 | $29.01 | $3,249 |
Medicare prescription drug claims, 2024
In 2024, the drug Shayhira Suazo Herrera prescribed most often to Medicare patients was Levothyroxine Sodium, with 901 prescriptions and refills. In total Shayhira Suazo Herrera wrote 6,928 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 901 | 2,652 | 272 | $9,775 |
| Ozempic Semaglutide | 388 | 681 | 90 | $665K |
| Mounjaro Tirzepatide | 343 | 497 | 57 | $528K |
| Pioglitazone Hcl Generic | 298 | 868 | 96 | $2,692 |
| Jardiance Empagliflozin | 247 | 665 | 75 | $388K |
| Metformin Hcl Generic | 222 | 649 | 73 | $1,753 |
| Metformin Hcl Er Metformin Hcl | 221 | 615 | 73 | $2,608 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 213 | 599 | 101 | $30K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 208 | 582 | 86 | $33K |
| Synthroid Levothyroxine Sodium | 201 | 510 | 58 | $19K |
| Alendronate Sodium Generic | 174 | 460 | 57 | $1,149 |
| Tresiba Flextouch U-200 Insulin Degludec | 152 | 375 | 45 | $195K |
| Trulicity Dulaglutide | 135 | 242 | 37 | $240K |
| Tresiba Flextouch U-100 Insulin Degludec | 130 | 371 | 44 | $75K |
| Farxiga Dapagliflozin Propanediol | 126 | 251 | 34 | $137K |
Brand drugs: 3,822 claims; generic drugs: 2,570 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shayhira Suazo Herrera $2,525 ($2,525 in general payments such as food, travel and fees) from 31 companies. The largest payer was Lilly USA, LLC with $249.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 6 | $249 |
| Sanofi-Aventis U.S. LLC SNY | 8 | $223 |
| Inspire Medical Systems, Inc. INSP | 1 | $158 |
| Insulet Corporation PODD | 7 | $138 |
| Novo Nordisk Inc NVO | 5 | $129 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $121 |
| Actelion Pharmaceuticals US, Inc. JNJ | 1 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $120 |
| Abbott Laboratories ABT | 1 | $120 |
| Xeris Pharmaceuticals, Inc. | 5 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.